While it is ideal to remotely and continuously monitor all medical-surgical floor patients, we know that limited resources and time make it unfeasible for many institutions. The three targeted patient populations where our remote continuous monitoring solutions best align to provide the greatest impact are:
PRODIGY is a prospective, international multicenter study to identify individuals at high risk for OIRD, a form of respiratory compromise. The PRODIGY study found that 46 percent of hospitalized patients receiving parenteral opioids experienced significant respiratory depression episodes. Undetected, these may lead to more serious events - including respiratory failure. With the publication of the PRODIGY study, the PRODIGY Risk Prediction Tool is now available. It provides an easy to use, internally-validated means of scoring risk of OIRD based on 5 easy to obtain variables.
Download the PRODIGY Risk Prediction Tool, view an infographic of key study findings, download a Frequently Asked Questions document, or view the PRODIGY study at a glance to learn more.
Use the return-on-investment (ROI) calculator to see how much your medical-surgical unit could potentially reduce respiratory depression rate, length of stay, and admission costs by implementing PRODIGY and continuous monitoring.
The Microstream™ capnography, Nellcor™ pulse oximetry, and Vital Sync™ remote patient monitoring systems should not be used as the sole basis for diagnosis or therapy and are intended only as an adjunct in patient assessment.